Workflow
盈利预测修正
icon
Search documents
Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates
ZACKS· 2025-07-29 23:06
Company Performance - Teladoc reported a quarterly loss of $0.19 per share, better than the Zacks Consensus Estimate of a loss of $0.27, and an improvement from a loss of $0.28 per share a year ago, representing an earnings surprise of +29.63% [1] - The company posted revenues of $631.9 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.77%, although this is a decrease from year-ago revenues of $642.44 million [2] - Over the last four quarters, Teladoc has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Stock Outlook - Teladoc shares have underperformed the market, losing about 9.8% since the beginning of the year, while the S&P 500 has gained 8.6% [3] - The current consensus EPS estimate for the coming quarter is -$0.21 on revenues of $627.2 million, and for the current fiscal year, it is -$1.21 on revenues of $2.51 billion [7] Industry Context - The Medical Services industry, to which Teladoc belongs, is currently in the top 37% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% of industries [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that industry outlook can materially impact stock performance [5][8]
Why A.P. Moller-Maersk (AMKBY) Might be Well Poised for a Surge
ZACKS· 2025-07-29 17:21
Group 1 - A.P. Moller-Maersk shows a noticeable improvement in earnings outlook, making it an attractive investment option [1][7] - Analysts are increasingly optimistic about the company's earnings prospects, reflected in the upward trend of earnings estimate revisions [2][3] - The Zacks Rank system indicates a strong correlation between earnings estimate revisions and stock price movements, with A.P. Moller-Maersk currently holding a Zacks Rank 2 (Buy) [3][6] Group 2 - The consensus earnings estimate for the current quarter is $0.13 per share, which is a 35.0% decrease from the previous year, but has increased by 250% over the last 30 days [4] - For the full year, the earnings estimate is $0.34 per share, representing an 82.5% decrease from the year-ago number, with a recent increase of 17.44% in the consensus estimate [5] - The stock has gained 13.2% over the past four weeks, driven by solid estimate revisions and positive earnings growth prospects [7]
Countdown to Etsy (ETSY) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-07-29 05:06
Core Viewpoint - Analysts forecast Etsy (ETSY) will report quarterly earnings of $0.54 per share, reflecting a year-over-year increase of 31.7%, with revenues expected to be $648.01 million, showing no change from the previous year [1]. Earnings Estimates - Over the last 30 days, there has been a 0.7% upward revision in the consensus EPS estimate for the quarter, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts project 'Revenue- Services' to reach $189.56 million, representing a year-over-year increase of 6.8% [4]. - The estimated 'Revenue- Marketplace' is $459.65 million, indicating a year-over-year decline of 2.3% [5]. - Total Gross Merchandise Sales (GMS) are expected to be $2.77 million, down from $2.95 million in the same quarter last year [5]. Active User Metrics - Analysts estimate 'Active buyers' will total 94,648, a decrease from 96,610 reported in the same quarter of the previous year [5]. - The consensus for 'Active sellers' is 8,155, down from 8,801 in the same quarter last year [6]. Stock Performance - Shares of Etsy have increased by 23.3% over the past month, outperforming the Zacks S&P 500 composite, which rose by 4.9% [6].
Hasbro (HAS) Upgraded to Strong Buy: What Does It Mean for the Stock?
ZACKS· 2025-07-28 17:01
Core Viewpoint - Hasbro (HAS) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook for its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates as a key driver of stock price movements, with a strong correlation observed between earnings estimate revisions and near-term stock performance [4][6]. - For the fiscal year ending December 2025, Hasbro is projected to earn $4.70 per share, which remains unchanged from the previous year, but the Zacks Consensus Estimate has increased by 7.2% over the past three months [8]. Zacks Rating System - The Zacks Rank stock-rating system categorizes stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - The upgrade of Hasbro to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].
How Much Upside is Left in Kennedy-Wilson (KW)? Wall Street Analysts Think 30.26%
ZACKS· 2025-07-28 14:55
Group 1 - Kennedy-Wilson (KW) closed at $7.6, with a 9.2% gain over the past four weeks, and a mean price target of $9.9 indicating a 30.3% upside potential [1] - The average price targets range from a low of $7.70 to a high of $13.00, with a standard deviation of $2.76, suggesting variability in analyst estimates [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for KW has increased by 109.1% due to one estimate moving higher over the last 30 days without any negative revisions [12] - KW holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can indicate the direction of price movement [14]
Wall Street Analysts Believe Revolution Medicines (RVMD) Could Rally 90.58%: Here's is How to Trade
ZACKS· 2025-07-28 14:55
Group 1 - Revolution Medicines, Inc. (RVMD) shares have increased by 2.7% over the past four weeks, closing at $37.91, with a mean price target of $72.25 indicating a potential upside of 90.6% [1][2] - The mean estimate consists of 12 short-term price targets with a standard deviation of $7.86, where the lowest estimate is $57.00 (50.4% increase) and the highest is $88.00 (132.1% increase) [2] - Analysts show strong agreement on RVMD's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for RVMD's current year earnings has increased by 1% over the last 30 days, with one estimate moving higher and no negative revisions [12] - RVMD holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the stock's potential gain, it does provide a directional guide for price movement [14]
Wall Street Analysts See a 60.15% Upside in Geo Group (GEO): Can the Stock Really Move This High?
ZACKS· 2025-07-28 14:55
Core Viewpoint - Geo Group (GEO) has shown a significant price increase of 9.8% over the past four weeks, with a mean price target of $41.8 indicating a potential upside of 60.2% from the current price of $26.1 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $6.42, where the lowest estimate is $35.00 (34.1% increase) and the highest is $50.00 (91.6% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Consensus - Analysts have shown increasing optimism about GEO's earnings prospects, with a positive trend in earnings estimate revisions indicating potential upside [11] - The Zacks Consensus Estimate for the current year has risen by 3.9% over the past month, with no negative revisions [12] - GEO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, as empirical research shows they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]
Can Hagerty (HGTY) Run Higher on Rising Earnings Estimates?
ZACKS· 2025-07-25 17:21
Core Viewpoint - Hagerty, Inc. (HGTY) is positioned as a strong investment opportunity due to significant upward revisions in earnings estimates, indicating a positive earnings outlook that may continue to drive stock price growth [1][2]. Earnings Estimate Revisions - Analysts have shown growing optimism regarding Hagerty's earnings prospects, reflected in the upward trend of earnings estimate revisions, which historically correlate with stock price movements [2]. - The current-quarter earnings estimate is $0.13 per share, representing an 8.3% increase from the previous year, with a 6.45% rise in the Zacks Consensus Estimate over the last 30 days, indicating no negative revisions [7]. - For the full year, the expected earnings are $0.35 per share, marking a 45.8% increase from the prior year, with a similar trend of one upward revision and no negative changes in estimates [8]. Zacks Rank and Performance - The positive revisions have led to Hagerty earning a Zacks Rank 1 (Strong Buy), which is associated with a strong historical performance, averaging a 25% annual return since 2008 for Zacks 1 ranked stocks [3][9]. - Stocks with Zacks Rank 1 and 2 are shown to significantly outperform the S&P 500, reinforcing the potential for Hagerty's stock to deliver strong returns [9]. Market Reaction - The stock has gained 5.6% over the past four weeks, driven by favorable estimate revisions, suggesting that investors are increasingly confident in Hagerty's earnings growth prospects [10].
Envista (NVST) Upgraded to Strong Buy: Here's What You Should Know
ZACKS· 2025-07-25 17:00
Core Viewpoint - Envista (NVST) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which have a strong correlation with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to institutional investors adjusting their valuations, resulting in stock price movements [4]. Company Performance and Outlook - The recent upgrade for Envista suggests an improvement in its underlying business, which could lead to higher stock prices as investors respond positively [5][10]. - For the fiscal year ending December 2025, Envista is expected to earn $1.04 per share, with a 6% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Envista's upgrade places it in the top 5% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].
Wall Street Analysts Think Kimbell Royalty (KRP) Could Surge 27.4%: Read This Before Placing a Bet
ZACKS· 2025-07-25 14:56
Group 1 - Kimbell Royalty (KRP) shares have increased by 4.4% over the past four weeks, closing at $14.6, with a mean price target of $18.6 indicating a potential upside of 27.4% [1] - The average price targets range from a low of $12.00 to a high of $24.00, with a standard deviation of $4.98, suggesting variability in analyst estimates [2] - Analysts show a consensus that KRP will report better earnings than previously estimated, which historically correlates with stock price increases [4][11] Group 2 - The Zacks Consensus Estimate for KRP's current year earnings has risen by 45.9% over the last 30 days, with two estimates moving higher and no negative revisions [12] - KRP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of KRP's gains, they can provide guidance on the direction of price movement [14]